IDEXX Laboratories, Inc. (IDXX): Price and Financial Metrics


IDEXX Laboratories, Inc. (IDXX)

Today's Latest Price: $429.66 USD

6.07 (1.43%)

Updated Oct 23 4:00pm

Add IDXX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

IDXX Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for IDXX is 9.07 -- better than 96.36% of US stocks.
  • With a one year PEG ratio of 654.72, Idexx Laboratories Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 94.62% of US stocks.
  • The price/operating cash flow metric for Idexx Laboratories Inc is higher than 94.82% of stocks in our set with a positive cash flow.
  • If you're looking for stocks that are quantitatively similar to Idexx Laboratories Inc, a group of peers worth examining would be CLX, EBAY, ROK, BBY, and CVNA.
  • IDXX's SEC filings can be seen here. And to visit Idexx Laboratories Inc's official web site, go to www.idexx.com.

IDXX Stock Price Chart Interactive Chart >

Price chart for IDXX

IDXX Price/Volume Stats

Current price $429.66 52-week high $431.15
Prev. close $423.59 52-week low $168.65
Day low $423.55 Volume 227,300
Day high $429.73 Avg. volume 548,279
50-day MA $388.10 Dividend yield N/A
200-day MA $317.13 Market Cap 36.54B

IDEXX Laboratories, Inc. (IDXX) Company Bio


IDEXX Laboratories develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. The company was founded in 1983 and is based in Westbrook, Maine.

IDXX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$429.66$63.53 -85%

We started the process of determining a valid price forecast for Idexx Laboratories Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Idexx Laboratories Inc ranked in the 14th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for IDXX, they are:

  • The company's debt burden, as measured by earnings divided by interest payments, is 18.74 -- which is good for besting 83.4% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • The business' balance sheet reveals debt to be 3% of the company's capital (with equity being the remaining amount). Approximately merely 10.77% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • IDXX's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 47.78% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-85%
1%-85%
2%-85%
3%-85%
4%-85%
5%-84%

MYGN, LMNX, QGEN, BSX, and ELAN can be thought of as valuation peers to IDXX, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


IDXX Latest News Stream


Event/Time News Detail
Loading, please wait...

IDXX Latest Social Stream


Loading social stream, please wait...

View Full IDXX Social Stream

Latest IDXX News From Around the Web

Below are the latest news stories about Idexx Laboratories Inc that investors may wish to consider to help them evaluate IDXX as an investment opportunity.

Veterinary Imaging Market worth USD 2.2 billion by 2025 | Leading Companies are GE Healthcare, Agfa-Gevaert N.V, Carestream Health, Esaote S.p.A, IDEXX Laboratories, and Mindray Medical International Limited

According to the new market research report "Veterinary Imaging Market by Product (Ultrasound (2D, Doppler, 3D), X-ray (CR, DR), MRI, CT, Software, Reagent), Therapeutic Area (Oncology, Gynecology, Orthopedic), Animal (Small Companion, Large), End User (Hospital, Clinic) - Global Forecast to

OpenPR | September 28, 2020

IDEXX Laboratories to Host Virtual Investor Day

WESTBROOK, Maine, Aug. 10, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host its 2020 virtual Investor Day on Thursday, August 13, 2020 from 10:00 am – 12:00 pm ET….

PR Newswire | August 10, 2020

IDEXX Laboratories Inc (IDXX) Q2 2020 Earnings Call Transcript

IDXX earnings call for the period ending June 29, 2020.

Yahoo | July 31, 2020

IDEXX (IDXX) Earnings Beat Estimates in Q2, Margins Rise

IDEXX Laboratories (IDXX) registered strong contribution from its CAG business despite the pandemic-led challenges.

Yahoo | July 31, 2020

Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year?

Is (IDXX) Outperforming Other Medical Stocks This Year?

Yahoo | July 31, 2020

Read More 'IDXX' Stories Here

IDXX Price Returns

1-mo 17.56%
3-mo 19.61%
6-mo 55.76%
1-year 60.15%
3-year 165.16%
5-year 465.79%
YTD 64.54%
2019 40.38%
2018 18.95%
2017 33.35%
2016 60.82%
2015 -1.64%

Continue Researching IDXX

Here are a few links from around the web to help you further your research on Idexx Laboratories Inc's stock as an investment opportunity:

Idexx Laboratories Inc (IDXX) Stock Price | Nasdaq
Idexx Laboratories Inc (IDXX) Stock Quote, History and News - Yahoo Finance
Idexx Laboratories Inc (IDXX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8848 seconds.